Company
Headquarters: Taichung, Taiwan
Employees: 196
TW$936.5 Million
TWD as of July 1, 2025
US$32.0 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Roche | $260.54 B |
| Novartis | $243.50 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Yung Zip Chemical Ind. Co., Ltd., a bulk drug manufacturing company, supplies active pharmaceutical ingredients (APIs), API intermediates, and specialty chemicals worldwide. It offers antihypertensive, anti-viral, iron chelator, anti-inflammatory, analgesic, antipyretic, anti-fungal, anti-cancer, schizophrenia, anticoagulant, genital herpes outbreak, hypnotic, and sedative products. The company also offers excipients, such as sodium starch glycolate; and custom research and manufacturing services. The company was founded in 1978 and is based in Taichung, Taiwan.
Yung Zip Chemical Ind. Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4102 wb_incandescent